Permanently Discontinued

APO-NIFED PA - SRT 20MG

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is APO-NIFED PA - SRT 20MG discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that APO-NIFED PA - SRT 20MG has been permanently discontinued (last updated October 5, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is APO-NIFED PA - SRT 20MG not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products · 5 same form & route

Affected strength20MG

Report last updated2017-10-05

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.

Other Products

NIFEDIPINE

AA PHARMA INC

10MG · DIN 00755907

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02181525

Strength

20MG

Dosage Form

TABLET (EXTENDED-RELEASE)

Route

ORAL

Active Ingredient

NIFEDIPINE

See all NIFEDIPINE products →

Compare with another product →

Product Monograph

Product monograph is not available from Health Canada

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2017-10-05

Active Shortage

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244